1. Home
  2. ASMB vs ACU Comparison

ASMB vs ACU Comparison

Compare ASMB & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • ACU
  • Stock Information
  • Founded
  • ASMB 2005
  • ACU 1867
  • Country
  • ASMB United States
  • ACU United States
  • Employees
  • ASMB N/A
  • ACU N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • ACU Industrial Machinery/Components
  • Sector
  • ASMB Health Care
  • ACU Consumer Discretionary
  • Exchange
  • ASMB Nasdaq
  • ACU Nasdaq
  • Market Cap
  • ASMB 141.8M
  • ACU 145.9M
  • IPO Year
  • ASMB 2010
  • ACU N/A
  • Fundamental
  • Price
  • ASMB $18.51
  • ACU $41.52
  • Analyst Decision
  • ASMB Strong Buy
  • ACU
  • Analyst Count
  • ASMB 3
  • ACU 0
  • Target Price
  • ASMB $33.00
  • ACU N/A
  • AVG Volume (30 Days)
  • ASMB 43.3K
  • ACU 37.5K
  • Earning Date
  • ASMB 08-07-2025
  • ACU 07-22-2025
  • Dividend Yield
  • ASMB N/A
  • ACU 1.44%
  • EPS Growth
  • ASMB N/A
  • ACU N/A
  • EPS
  • ASMB N/A
  • ACU 2.48
  • Revenue
  • ASMB $32,154,000.00
  • ACU $195,491,991.00
  • Revenue This Year
  • ASMB $0.04
  • ACU $4.87
  • Revenue Next Year
  • ASMB N/A
  • ACU $3.65
  • P/E Ratio
  • ASMB N/A
  • ACU $16.82
  • Revenue Growth
  • ASMB 148.33
  • ACU 2.56
  • 52 Week Low
  • ASMB $7.75
  • ACU $32.85
  • 52 Week High
  • ASMB $19.93
  • ACU $50.00
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 63.34
  • ACU 58.93
  • Support Level
  • ASMB $18.13
  • ACU $42.57
  • Resistance Level
  • ASMB $19.11
  • ACU $44.88
  • Average True Range (ATR)
  • ASMB 0.81
  • ACU 1.32
  • MACD
  • ASMB -0.06
  • ACU 0.09
  • Stochastic Oscillator
  • ASMB 77.83
  • ACU 65.89

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

Share on Social Networks: